Рубрика
Blog
-
2023
-
FDA Approves FoundationOne Liquid CDx to Identify Genomic Profile in NSCLC
-
Roche’s Lunsumio Gets Accelerated Approval for Later-Line Follicular Lymphoma
-
FDA Grants Priority Review to Roche’s Glofitamab BLA in Large B-Cell Lymphoma
-
ACELYRIN acquires ValenzaBio, strengthens immunology position
-
FDA Approves Briumvi for Relapsing Multiple
-
FDA Approves Actemra for Hospitalized Adults with COVID-19
-
FDA slaps partial hold on Biogen, InnoCare MS drug
-
AZ announces US fast track designation for IL-5 inhibitor Fasenra
-
Roche’s Lunsumio Gets Accelerated Approval for Later-Line Follicular Lymphoma
-
Study Results Show Direct Evidence of Serotonin Disruption Linked With Depression